Trinity Life Sciences

Meet Rachel Lempp, a Senior Consultant on Trinity’s Launch Excellence team. 

We made the Inc. 5000 list of fastest growing private companies in America for the fourth consecutive year!        Learn more in our news release: https://bit.ly/4fOVr6E  

Trinity Life Sciences' Intelligence Newsletter brings you the latest thought leadership in the form of advisory briefs, white papers, webinars and more. View our latest Trinity Intelligence newsletter now: https://bit.ly/3yXuYTS 

In recognition of Women's Equality Day, we asked Trinitrons: "In one word or phrase, what does being an ally for gender equality mean to you?" The answers were inspiring.     They show that being an ally is not just about taking action but also about having the right mindset. It's about recognizing that gender equality is not just a women's issue but a human issue that affects us all. It's about being willing to learn and grow, and to help others do the same.  

Meet Neil Rath, PhD, an Engagement Manger on Trinity's Launch Excellence team.

Read the brief now: https://bit.ly/3WOmNT8      Launching a novel therapy with limited funding is already difficult, but it becomes even more daunting when the success of the product and the company are intertwined. Fortunately, there is a strategy that can increase your chances of success.      In this advisory brief, Trinity Life Sciences will explore the “molecular optimizer” archetype — a strategy utilized by first-launch companies to focus on the optimization of an existing molecule as their first product. Additionally, we will delve into the advantages and disadvantages of employing this approach. 

Join us as we explore how U.S. policy changes are impacting health plans, how health plan decision-making needs to adapt, and what this means for biopharma companies. The webinar will feature an engaging panel discussion hosted by Max Hunt, Partner at Trinity Life Sciences, with special guests Stephen George and Matthew Hayes, clinical and actuarial experts at Milliman.

“It was important for me to join an organization that had the building blocks to create Customer Engagement solutions that combine strategy, insights and analytics to see connectivity across patients, physicians and payers and meaningfully help our clients achieve their commercialization ambitions,” said Nancy Phelan, SVP and Head of Customer Engagement at Trinity Life Sciences. “Trinity, with its almost 30 years’ experience in life sciences, offers expertise and sophisticated tools to allow clients to look around the corner and see what their customers need.” Read more in our latest news release: https://bit.ly/3WT0HgX

Congratulations to our General Counsel, Paul Lucchese, for being listed as one of the Top 25 General Counsels in Biotechnology of 2024 by Attorney Intel. Read more about the award here: https://lnkd.in/gsGDCder

https://bit.ly/4c9bOrW Read our blog series, “Rise with the Waves: State of the Global Policy Landscape” which focuses on policy updates in Germany, Italy, Canada, France and the UK and the impact for pharmaceutical manufacturers.